Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Sequestration and Pharmacokinetics of Cefiderocol in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)

NCT04995835 is registered in ClinicalTrials.gov with Joseph L. Kuti, PharmD as lead sponsor.

NCT NCT04995835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04995835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Sequestration and Pharmacokinetics of Cefiderocol in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
Lead sponsor
Joseph L. Kuti, PharmD
Phase
Phase 1
Overall status
Completed
Start date
July 16, 2021
Completion date
September 1, 2024
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis